Ytterbium-176 Isotope

Access Ytterbium-176 isotope enriched to over 99.5%, delivered in metal or oxide form, for the production of Lutetium-177 used in oncology for targeted cancer radiotherapies.

• Challenges

  • Produce ¹⁷⁷Lu from enriched ¹⁷⁶Yb isotope
  • Meet the growing demand for targeted radionuclide therapy in cancer treatment
  • Ensure isotopic purity
  • Secure access to a strategic precursor for your clinical and industrial needs
  • Plan for future scale-up with a reliable European industrial partner

• Our Solution

  • Access enrichment levels above 99.5% for ¹⁷⁶Yb using the SILVA process, laser isotope separation technology developed with the CEA and tailored for lanthanides
  • Get a solution suited to the production of ¹⁷⁷Lu for next-generation oncology treatments
  • Choose the chemical form that fits your processes (metal or oxide)
  • Rely on a secure European supply chain, with production at the Tricastin site

• Key Features

  • >99.5% enrichment of ¹⁷⁶Yb via laser isotopic separation (SILVA)
  • SILVA process developed in partnership with the CEA
  • European production site: Tricastin, France
  • Available forms: metal or oxide
  • High isotopic purity meeting radiopharmaceutical needs

  

  Exploded view of the Stable Isotopes Laboratory

• Useful Links

  

  Visit Orano Stable Isotopes website !